alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.770 Express withdrawal of application for extension of patent term.

An application for extension of patent term may be expressly withdrawn before a determination is made pursuant to § 1.750 by filing in the Office a written declaration of withdrawal signed by the owner of record of the patent or its agent. An application may not be expressly withdrawn after the date permitted for reply to the final determination on the application. An express withdrawal pursuant to this section is effective when acknowledged in writing by the Office. The filing of an express withdrawal pursuant to this section and its acceptance by the Office does not entitle applicant to a refund of the filing fee (§ 1.20(j)) or any portion thereof.

[62 FR 53201, Oct. 10, 1997, as amended at 88 FR 13033, Mar. 2, 2023]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
HomeAnti-Corruption and Transparency...Anti-Corruption and Transparency

# Anti-Corruption and Transparency

125 items

        -    Funding Opportunity Announcement  		DRL: Reducing Corruption in Angola	  February 16, 2021 
        -    Funding Opportunity Announcement  		DRL – Promoting Investigative Journalism and Anti-Corruption Efforts in Pacific Island Countries	  February 16, 2021 
        -    		Anticrime Sanctions and Deterrence Tools	   
        -    Report  		2020 Fiscal Transparency Report	  June 15, 2020 
        -    Report  		2019 Fiscal Transparency Report	  August 15, 2019 
        -    Report  		Fiscal Transparency Report	   
        -    		Bureau of International Narcotics and Law Enforcement Affairs – Key Topics	   
        -    		Contact Us	   
        -    		Key Topics	   
        -    		Fiscal Transparency Innovation Fund	   

previous page1…910111213next page

Back to Top
August 9 , 2011



### JUDGMENT 

## The Fourteenth Court of Appeals

WOODY K. LESIKAR SPE CIAL TRUST AND WOODR OW V. LESIKAR FAMILY TRUST, THROUGH THEIR TRUSTEE, WOODY K. LE SIKAR, AND THE ESTAT E OF WOODROW V. LESIKA R, DECEASED, THROUGH ITS EXECUTOR, WOODY K. LESIKAR , Appellants

NO. 14

- 10

- 00119

- CV V.

CAROLYN ANN LESIKAR MOON, INDIVIDUALLY A ND AS NAMED TRUSTEE OF THE CAROLYN ANN L ESIKAR MOON SPECIAL TRUST , Appellee

____________________ This cause, an appeal from the turnover order in fav or of appellee, CAROLYN ANN LESIKAR MOON, IN DIVIDUALLY AND AS NA MED TRUSTEE OF THE
CAROLYN ANN LESIKAR MOON SPECIAL TRUST , signed January 29, 2010, was heard on the transcript of the record. We have inspected the record and find error in the judgment. We therefore MODIFY the turnover order of the court below by removing those provisions (1) ordering the releas e of “all liens or encumbrances of any type recorded against property awarded to the Carolyn Ann Lesikar Moon Special Trust in the Final Judgment si gned September 15, 200 5

. . . ;” (2) ordering appellants to “ sign or

execut e any other documents

. . . to clear any title issues relating to the property

. . . ;” and ( 3 ) prohibiting appellants from “execut ing
, filing, placing, or recording any liens or encumbrances of any type against the property.

. . . ”

We order the turnover order of the court below AFFIRMED except as modified in this judgment. Each party shall be responsible for its own costs incurred because of this appeal. We furt her order this decision certified below for observance.
EXHIBIT 32.1



SECTION 1350 CERTIFICATION



BY CHIEF EXECUTIVE
OFFICER



I, Richard E. Stoddard, Chief
Executive Officer of Kaiser Ventures LLC (the Company), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:



1. The amended Quarterly Report on Form 10-Q/A of the Company for the quarterly period ended September 30, 2001 (the
Report), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and



2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                       |  |                                       
|---------------------- |  | --------------------------------------
|Date: December 2, 2004 |  | /s/ Richard E. Stoddard               
|                       |  | Richard E. Stoddard                   
|                       |  | Chairman of the Board, President & CEO



A signed original of
this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
#### § 1.660 Expeditious handling.

No patent may be granted where the invention has been in public use or publicly disclosed for more than one year before filing of a patent application. Hence, submissions involving inventions should be made as promptly as possible in order to avoid delay which might jeopardize title to the invention or impair the rights of the inventor or the Government.

[61 FR 29659, June 12, 1996]
```

[House Report 107-365]
[From the U.S. Government Publishing Office]

107th Congress                                                   Report
                        HOUSE OF REPRESENTATIVES
 2d Session                                                     107-365

======================================================================

 
      PROVIDING FOR CONSIDERATION OF MOTIONS TO SUSPEND THE RULES

                                _______
                                

   March 5, 2002.--Referred to the House Calendar and ordered to be 
                                printed

                                _______
                                

   Mr. Sessions, from the Committee on Rules, submitted the following

                              R E P O R T

                       [To accompany H. Res. 354]

    The Committee on Rules, having had under consideration 
House Resolution 354, by a nonrecord vote, report the same to 
the House with the recommendation that the resolution be 
adopted.

                summary of provisions of the resolution

    The resolution provides that the following measures may be 
considered under suspension of the rules at any time on the 
legislative day of Wednesday, March 6, 2002:
    (1) The joint resolution (S.J. Res. 32) congratulating the 
United States Military Academy at West Point on its 
bicentennial anniversary, and commending its outstanding 
contributions to the Nation.
    (2) The bill (S. 1857) to encourage the negotiated 
settlement of tribal claims.
    (3) The bill (H.R. 1870) to provide for the sale of certain 
real property within the Newlands Project in Nevada, to the 
city of Fallon, Nevada.
    (4) The bill (H.R. 1883) to authorize the Secretary of the 
Interior to conduct a feasibility study on water optimization 
in the Burnt River basin, Malheur River basin, Owyhee River 
basin, and Powder River basin, Oregon.
    (5) The bill (H.R. 1963) to amend the National Trails 
System Act to designate the route taken by American soldier and 
frontiersman George Rogers Clark and his men during the 
Revolutionary War to capture the British forts at Kaskaskia and 
Cahokia, Illinois, and Vincennes, Indiana, for study for 
potential addition to the National Trails System.
    (6) A bill to provide assistance to displaced workers by 
extending unemployment benefits and by providing a credit for 
health insurance costs, and for other purposes.
    (7) A resolution expressing support for the democratically 
elected government of Colombia and its efforts to counter 
threats from United States-designated foreign terrorist 
organizations.

                                  

```
§ 222.20 Evidence. ( a ) *Admissibility.* All evidence that is relevant and not unduly repetitious or privileged shall be admissible. Evidence which has authentication or credibility issues will have its weight discounted accordingly. The Board reserves the right to discount evidence or not admit evidence with serious credibility issues entirely, or to request clarification from a party.
( b ) *Examination of witnesses.* All witnesses testifying at a hearing before the Board shall be required to take an oath or affirmation before testifying. At a hearing, any member of the Board may administer oaths and affirmations, ask questions of any witness, and each party shall have the opportunity to ask questions of each witness and the other parties. The Board shall manage the conduct of the hearing and may limit the number of witnesses or scope of questioning.
( c ) *Exhibits in hearing* — ( 1 ) *Submission.* Unless they are specifically excluded by the Board's own initiative or due to the Board's ruling on an objection raised by a party, all documents submitted by the parties through their statements submitted under § 222.15 shall be deemed admitted and marked as exhibits in the same order as presented through the documentary evidence a party submitted with the party statement. To the extent additional documents are allowed by the Board at a hearing on the merits, such evidence may also be presented as exhibits to all parties and marked by the presenting party starting with the next number after the exhibits attached to the party's document statement.
( 2 ) *Summary exhibits.* The contents of voluminous documentary evidence which cannot be conveniently examined at the hearing may be presented in the form of a chart, summary, or calculation. Absent leave of the Board, evidence supporting the summary exhibit must have been produced to the other parties in discovery and admitted as exhibits, and the summary exhibit must be disclosed to the other parties in the proceeding at least seven days before the hearing.
( d ) *New exhibits for use in cross-examination or redirect examination.* Exhibits not submitted as part of written testimony may not be used at a hearing without leave of the Board. Leave to use such exhibits may be requested before or during the hearing. Requests to use an exhibit not submitted as part of written testimony and any responses thereto shall follow the procedures set forth in § 220.5(a)(1) of this subchapter.
[87 FR 30077, May 17, 2022]
§ 85a.3 Authority for investigations of places of employment. ( a ) NIOSH authorized representatives who have been issued official NIOSH credentials are authorized by the Director, NIOSH, under sections 20 and 8 of the OSH Act, sections 501 and 103 of the FMSH Act, and this part. To enter without delay any place of employment for the purpose of conducting investigations of all pertinent processes, conditions, structures, machines, apparatus, devices, equipment, and materials within the place of employment; and to conduct medical examinations, anthropometric measurements and functional tests of employees within the place of employment as may be directly related to the specific investigation being conducted. Such investigations will be conducted in a reasonable manner, during regular working hours or at other reasonable times and within reasonable limits. In connection with any investigations, such NIOSH authorized representatives may question privately any employer, owner, operator, agent, or employee from the place of employment; and review, abstract, or duplicate employment records, medical records, records required by the Act and regulations, and other related records. In those instances where systems of records subject to review, abstraction or duplication are of a confidential nature, such as medical records, and are abstracted or duplicated, NIOSH will maintain such systems in accordance with the Privacy Act of 1974 (5 U.S.C. 552a) and the implementing regulation of the Department of Health and Human Services (45 CFR part 5b).
( b ) Areas under investigation which contain information classified by any agency of the United States Government in the interest of national security will be investigated only by NIOSH authorized representatives who have obtained the appropriate security clearance and authorization.
[41 FR 45002, Oct. 14, 1976, as amended at 45 FR 2654, Jan. 14, 1980]
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF INCOME FROM THE
SEPTEMBER 30, 1996 FORM 10-Q REPORT AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JUL-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                       6,770,000
<SECURITIES>                                         0
<RECEIVABLES>                                2,646,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             9,416,000
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                             102,851,000
<CURRENT-LIABILITIES>                        7,637,000
<BONDS>                                      8,162,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       315,000
<OTHER-SE>                                  75,844,000
<TOTAL-LIABILITY-AND-EQUITY>               102,851,000
<SALES>                                              0
<TOTAL-REVENUES>                             6,802,000
<CGS>                                                0
<TOTAL-COSTS>                                2,442,000
<OTHER-EXPENSES>                             2,690,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             406,000
<INCOME-PRETAX>                              1,264,000
<INCOME-TAX>                                   547,000
<INCOME-CONTINUING>                            717,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   717,000
<EPS-PRIMARY>                                     $.07
<EPS-DILUTED>                                     $.07
        

</TABLE>
###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

#### § 4.5 Notice by publication.

If the copy of the complaint that is mailed to the invention promoter is returned undelivered, then the USPTO will primarily publish a Notice of Complaint Received on the USPTO's Internet home page at *http://www.uspto.gov.* Only where the USPTO's Web site is unavailable for publication will the USPTO publish the Notice of Complaint in the *Official Gazette* and/or the Federal Register. The invention promoter will be given 30 days from such notice to submit a reply to the Notice of Complaint. If the USPTO does not receive a reply from the invention promoter within 30 days, the complaint alone will become publicly available.

[68 FR 9553, Feb. 28, 2003]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
In addition, granting the present amendment will further the public interest by allowing

Sensurion, Inc. to safely, efficiently, and economically to use the Sensurion MP
-4 and MP
-4T for aerial data collection. The enhanced safety achieved using an unmanned aircraft with the specifications described in this amendment, and carrying no passengers or crew, rather than a manned aircraft of significantly greater proportions, carrying crew in addition to flammable fuel, gives the FAA good cause to find that the additional UAS capabilities and operation enabled by this amendment is in the public interest. As the FAA has noted in the original exemption , this amendment is not precedent setting, that good cause exists for not publishing a summary of the petition in the Federal Register and that any delay in acting on the amendment would be detrimental to the organization. Thank you for your time in regards to this petition and please direct any correspondence to me.
Captain David E. B. Strohm Director of Operations Sensurion Inc., d.b.a. Sensurion Aerospace david.strohm@sensurion.com cc: Mr. Joe Burns Mr. Dan Johnson Mr. Brian Haynes Mr. Mike Haynes Attachment: Original Exemption No. 13522 Docket No. FAA
-2015 -3542
#### § 93.208 Evidence.

*Evidence* means any document, tangible item, or testimony offered or obtained during a research misconduct proceeding that tends to prove or disprove the existence of an alleged fact.
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2245 Introduced in House (IH)]

110th CONGRESS
  1st Session
                                H. R. 2245

 To designate the Department of Veterans Affairs outpatient clinic in 
    Wenatchee, Washington, as the Elwood ``Bud'' Link Department of 
                  Veterans Affairs Outpatient Clinic.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 9, 2007

  Mr. Hastings of Washington introduced the following bill; which was 
             referred to the Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
 To designate the Department of Veterans Affairs outpatient clinic in 
    Wenatchee, Washington, as the Elwood ``Bud'' Link Department of 
                  Veterans Affairs Outpatient Clinic.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION OF ELWOOD ``BUD'' LINK DEPARTMENT OF VETERANS 
              AFFAIRS OUTPATIENT CLINIC.

    (a) Designation.--The Department of Veterans Affairs outpatient 
clinic located in Wenatchee, Washington, shall after the date of the 
enactment of this Act be known and designated as the ``Elwood `Bud' 
Link Department of Veterans Affairs Outpatient Clinic''.
    (b) References.--Any reference in any law, regulation, map, 
document, record, or other paper of the United States to the medical 
center referred to in subsection (a) shall be considered to be a 
reference to the Elwood ``Bud'' Link Department of Veterans Affairs 
Outpatient Clinic.
                                 <all>
```
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.22 Fees payable in advance.

(a) Patent fees and charges payable to the United States Patent and Trademark Office are required to be paid in advance; that is, at the time of requesting any action by the Office for which a fee or charge is payable, with the exception that under § 1.53 applications for patent may be assigned a filing date without payment of the basic filing fee.

(b) All fees paid to the United States Patent and Trademark Office must be itemized in each individual application, patent, or other proceeding in such a manner that it is clear for which purpose the fees are paid. The Office may return fees that are not itemized as required by this paragraph. The provisions of § 1.5(a) do not apply to the resubmission of fees returned pursuant to this paragraph.

[68 FR 48288, Aug. 13, 2003]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.